Relevance. Early detection of severe forms of acute pancreatitis remains an unsolved problem of urgent surgery.Objective of the study: early detection of prognostically unfavorable forms of the disease based on the constitutional characteristics of the patient.Materials and methods. A comparative prospective analysis of the clinical course of acute pancreatitis in 270 patients with an assessment of the prognostic significance of clinical, instrumental and anthropological data in the early diagnosis of severe forms of acute pancreatitis was carried out. In 179 patients there was a moderate and severe form of the disease, in 91 patients the disease was mild.Results and discussion. ROC analysis of the studied criteria showed that clinical and laboratory data on the first day of the disease are not reliable predictors of the risk of death. The somatotype and the amount of adipose tissue in the body (type of nutrition) showed a significant predictive value of AUC (0.768 and 0.655, p < 0.01 and p < 0.05, respectively). At the same time, only the body type AUC (0.658, p < 0.0001) showed statistical reliability as a significant prognostic factor for the progress severity of the patient's condition. The criti cal boundary calculated value of the somatotype is 20 nominal units. The risk group includes persons with a body type close to brachymorphic.Conclusion. Carrying out somatotyping with the calculation of its numerical values, attributing the patient to a particular type of physique in the group of patients with acute pancreatitis in the early stages from the moment of the disease, is an additional criterion for early prediction of the course of acute pancreatitis and will allow to determine the competent treatment to avoid manifestation of severe form of disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.